Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Standard 30-Minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated with Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Amyloidosis

David M. Hughes,Lynnette Henshaw,Frances Blevins,Camille Edwards,Adam Lerner,John Mark Sloan,Vaishali Sanchorawala

Clinical Lymphoma Myeloma and Leukemia（2022）

Cited 0|Views5
No score
Key words
subcutaneous daratumumab,multiple myeloma,light chain amyloidosis,pre-medications
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined